8 Biotech Stocks With Clinical Trial Outcomes In April By: Benzinga via Benzinga April 05, 2018 at 15:30 PM EDT The market-moving nature of clinical trial results is due to the fact that only a small proportion of drugs that move from pre-clinical ... Read More >> Related Stocks: Arqule Inc Blueprint Medicines Corp Galectin Therapeutic Nasdaq Biotechnology Ishares ETF Novartis Ag ADR Oncosec Medical Selecta Biosciences Tesaro Inc Tocagen Inc
